Special Topics
-
Multiple Trials Reflect Promise for New Methods to Treat COPD
on
Read more: Multiple Trials Reflect Promise for New Methods to Treat COPDBreakthroughs in the treatment of chronic obstructive pulmonary disease (COPD) appear to be on the horizon in thoracic medicine. Surya P. Bhatt, MD, MSPH, contextualized the encouraging results from multiple clinical trials discussed at the ATS 2024 International Conference.
-
Ongoing Research Efforts Reveal Key Insights to Advance Care for Bronchiectasis
on
Read more: Ongoing Research Efforts Reveal Key Insights to Advance Care for BronchiectasisRecent developments in bronchiectasis discussed at ATS 2024 reflect the growing interest and continued progression in advancing research and patient care for people with the disease. George M. Solomon, MD, shared his perspective on these continued efforts and why there’s reason for optimism moving forward.
-
New in Bronchiectasis: Novel Therapeutics and Disease Management Strategies
on
Read more: New in Bronchiectasis: Novel Therapeutics and Disease Management StrategiesThe latest advancements in the understanding of the epidemiology, pathophysiology, and therapies for bronchiectasis will be highlighted in the ATS 2024 International Conference scientific program. Nirupama Putcha, MD, MHS, previews the hot topics of discussion among bronchiectasis specialists.
-
New in COPD: Clinical Trials and Early COPD Research
on
Read more: New in COPD: Clinical Trials and Early COPD ResearchNew insights into the diagnosis, management, and prevention of COPD will be highlighted in the ATS 2024 International Conference scientific program. Nirupama Putcha, MD, MHS, discussed the important dialogues among COPD specialists and what these respiratory health professionals can expect from ATS 2024 San Diego this May.
-
Bronchiectasis & COPD Lineup at ATS 2024
on
Read more: Bronchiectasis & COPD Lineup at ATS 2024The ATS 2024 International Conference offers a robust scientific program featuring several Postgraduate Courses, Scientific Symposia, and Meet the Expert Sessions addressing new developments and considerations in bronchiectasis and COPD.
-
Trials Show Promise for New Agents to Treat COPD
on
Read more: Trials Show Promise for New Agents to Treat COPDSeveral trial results for the treatment of COPD were shared at the 2023 International Conference. Gerard J. Criner, MD, and David M. Mannino III, MD, discussed findings from the BOREAS trial, expectations from the ongoing NOTUS trial, and data from the ENHANCE-1 and ENHANCE-2 studies.
-
Ongoing Trials, Genetic Breakthroughs Pave the Way for Progress in Bronchiectasis
on
Read more: Ongoing Trials, Genetic Breakthroughs Pave the Way for Progress in BronchiectasisTimothy R. Aksamit, MD, FCCP, and Mark Metersky, MD, FCCP, comment on updates from multiple studies making headway in treating bronchiectasis. These trials, presented at the ATS 2023 International Conference, reflect research focusing on the three pillars of the disease: infection, inflammation, and mucociliary milieu. The trials included phase three of PROMIS II and phase…
-
New in Bronchiectasis: Advanced Understanding of Disease
on
Read more: New in Bronchiectasis: Advanced Understanding of DiseaseThe latest advancements in the understanding of the epidemiology, pathophysiology, and therapies of bronchiectasis will be highlighted in the ATS 2023 International Conference scientific program. Timothy R. Aksamit, MD, and Mark Metersky, MD, preview the hot topics of discussion among bronchiectasis specialists right now.
-
New in COPD: Early Disease and Classification Considerations
on
Read more: New in COPD: Early Disease and Classification ConsiderationsDavid M. Mannino III, MD, provides expert perspective on the important dialogue taking place among COPD specialists and what these respiratory health professionals can expect from the ATS 2023 International Conference in Washington, DC, this May.
-
International Conference Debut: Four Respiratory Societies Join to Discuss COPD in the Americas
on
Read more: International Conference Debut: Four Respiratory Societies Join to Discuss COPD in the AmericasThe Respiratory Societies of the Americas session will debut at the ATS 2023 International Conference with a focus on COPD, challenges to accessing medicine for this disease, and the impact on health policies throughout the Americas.